TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Swedish PharmaInsights AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
10,577
|
9,639
|
10,631 |
Financial expenses |
1
|
3
|
0 |
Earnings before taxes |
-304
|
1,099
|
2,002 |
EBITDA |
-371
|
1,101
|
2,002 |
Total assets |
7,302
|
6,995
|
6,560 |
Current assets |
7,302
|
6,995
|
6,560 |
Current liabilities |
2,636
|
2,029
|
2,305 |
Equity capital |
4,666
|
4,966
|
4,255 |
- share capital |
34
|
33
|
36 |
Employees (average) |
4
|
3
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.9%
|
71.0%
|
64.9% |
Turnover per employee |
2,644
|
3,213
|
5,316 |
Profit as a percentage of turnover |
-2.9%
|
11.4%
|
18.8% |
Return on assets (ROA) |
-4.1%
|
15.8%
|
30.5% |
Current ratio |
277.0%
|
344.8%
|
284.6% |
Return on equity (ROE) |
-6.5%
|
22.1%
|
47.1% |
Change turnover |
888
|
-130
|
1,122 |
Change turnover % |
9%
|
-1%
|
12% |
Chg. No. of employees |
1
![]() |
1
|
0 |
Chg. No. of employees % |
33%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.